COFIXRX Trademark

Trademark Overview


On Tuesday, March 28, 2023, a trademark application was filed for COFIXRX with the United States Patent and Trademark Office. The USPTO has given the COFIXRX trademark a serial number of 97981069. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Tuesday, December 30, 2025. This trademark is owned by CoFix-RX, LLC. The COFIXRX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances, used internally as pills and other solids, and also used as sprays and liquids for the treatment and prevention of killing viruses, bacteria, coronaviruses including COVID-19, SARS, biofilms, fungi, mold, and spores; Pharmaceutical preparations, namely, anti-infectives for use in or as chemotherapeutics; Pharmaceutical preparations for the treatment of viral diseases for use in or as chemotherapeutics; Disinfectants; Sanitizing preparations for household, commercial, and hospital use; All-purpose disinfectants for killing viruses, bacteria, coronaviruses including COVID-19, SARS, biofilms, fungi, mold, and spores; Nasal spray for the treatment and prevention of killing viruses, bacteria, coronaviruses including COVID-19, biofilms, fungi, mold, spores, wound medical cleansers, nasal cleaning solutions for medical purposes and Medicated throat spray
cofixrx

General Information


Serial Number97981069
Word MarkCOFIXRX
Filing DateTuesday, March 28, 2023
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateTuesday, December 30, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, March 12, 2024

Trademark Statements


Pseudo MarkCO FIX RX
Goods and ServicesPharmaceutical preparations and substances, used internally as pills and other solids, and also used as sprays and liquids for the treatment and prevention of killing viruses, bacteria, coronaviruses including COVID-19, SARS, biofilms, fungi, mold, and spores; Pharmaceutical preparations, namely, anti-infectives for use in or as chemotherapeutics; Pharmaceutical preparations for the treatment of viral diseases for use in or as chemotherapeutics; Disinfectants; Sanitizing preparations for household, commercial, and hospital use; All-purpose disinfectants for killing viruses, bacteria, coronaviruses including COVID-19, SARS, biofilms, fungi, mold, and spores; Nasal spray for the treatment and prevention of killing viruses, bacteria, coronaviruses including COVID-19, biofilms, fungi, mold, spores, wound medical cleansers, nasal cleaning solutions for medical purposes and Medicated throat spray
Description of MarkThe mark consists of the stylized wording "COFIXRX" with a large letter "C" encompassing the letter "O".

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 20, 2023
Primary Code005
First Use Anywhere DateSunday, January 1, 2023
First Use In Commerce DateSunday, January 1, 2023

Trademark Owner History


Party NameCoFix-RX, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBloomfield Hills, MI 48304

Party NameCoFix-RX, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBloomfield Hills, MI 48304

Trademark Events


Event DateEvent Description
Friday, March 31, 2023NEW APPLICATION ENTERED
Thursday, April 20, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 21, 2023ASSIGNED TO EXAMINER
Thursday, December 21, 2023NON-FINAL ACTION WRITTEN
Thursday, December 21, 2023NON-FINAL ACTION E-MAILED
Thursday, December 21, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 26, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 26, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 26, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 31, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 21, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 12, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 12, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 7, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, November 7, 2024SOU TEAS EXTENSION RECEIVED
Thursday, November 7, 2024SOU EXTENSION 1 FILED
Thursday, November 7, 2024SOU EXTENSION 1 GRANTED
Thursday, November 7, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 7, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, May 7, 2025SOU EXTENSION 2 FILED
Wednesday, May 7, 2025SOU EXTENSION 2 GRANTED
Thursday, May 8, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 26, 2025TEAS STATEMENT OF USE RECEIVED
Thursday, June 26, 2025TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, December 16, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 26, 2025DIVISIONAL REQUEST RECEIVED
Monday, December 29, 2025DIVISIONAL PROCESSING COMPLETE
Thursday, June 26, 2025USE AMENDMENT FILED
Monday, December 29, 2025STATEMENT OF USE PROCESSING COMPLETE
Tuesday, December 30, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, December 30, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED